VVUS

VIVUS, Inc. News Headlines

$1.51
*  
0.22
12.72%
Get VVUS Alerts
*Delayed - data as of Jul. 31, 2015  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By







Orexigen Posts Loss - Revenue Will Be The Story
5/8/2015 10:29:00 AM - Seeking Alpha








Why Vivus Is Undervalued At Anything Under $10 Per Share
4/30/2015 8:38:00 AM - Seeking Alpha






Orexigen: Contrave Sales Pop, Equity Response Muted
4/24/2015 7:39:00 PM - Seeking Alpha




Orexigen Investors Can Get Litigation Insight From Vivus
4/24/2015 8:29:00 AM - Seeking Alpha






Orexigen Faces Generic Challenge For Anti-Obesity Drug
4/22/2015 12:24:00 PM - Seeking Alpha




Vivus Sales Remain Flat - Stock Trend Not Good
4/13/2015 1:19:00 PM - Seeking Alpha




Novo Nordisk Quietly Becoming Big Player In Obesity Space
4/9/2015 11:45:00 AM - Seeking Alpha










Novo Nordisk Entry Is Bullish For The Anti-Obesity Space
4/2/2015 9:20:00 PM - Seeking Alpha